Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Yoav Littner, MD, is an Associate Staff Member with Cleveland Clinic Children’s Hospital Departments of Neonatology and Neurosciences. He sees patients at Main Campus and Hillcrest Hospital. In addition to his clinical responsibilities, Dr. Littner is Assistant Professor of Pediatrics for Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.
Dr. Littner is board certified in pediatrics and neonatology through the Ministry of Health, State of Israel. He completed his undergraduate degree at Technion School of Medicine in Haifa Israel, and he earned his medical degree from Technion-Israel Institute of Technology, Faculty of Medicine, also in Haifa Israel. His post-graduate training includes a rotating internship and pediatric residency at Sourasky Medical Center in Tel Aviv Israel and a neonatal-perinatal fellowship at University Hospitals of Cleveland.
Dr. Littner is a member of the Society of Pediatric Research, Society for Neuroscience, and the Research Society on Alcoholism. He has published multiple research articles in peer-reviewed journals, as well as having contributed abstracts and presentations at a number of professional association meetings. He also has contributed to several text books.
His specialty interests include care of complex surgical and neonatal disease; nutrition and bone health of preterm infants; music therapy in the NICU; environmental effects of toxins on the developing brain (such as alcohol and Mercury); effects of alcohol on development and migration of oligodendrocyte in the developing brain; and biomarkers for fetal ethanol exposure during pregnancy.
ICU care of complex infants bone health of preterm & term infants, quality of health care, patient safety
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 11/3/2015, Dr. Littner has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.